Home > Riviste > International Angiology > Fascicoli precedenti > International Angiology 2018 August;37(4) > International Angiology 2018 August;37(4):269-76

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi PROMO
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo

 

REVIEW   Freefree

International Angiology 2018 August;37(4):269-76

DOI: 10.23736/S0392-9590.18.03982-2

Copyright © 2018 EDIZIONI MINERVA MEDICA

lingua: Inglese

Risk assessment as a guide for the prevention of cancer-associated thromboembolism

Ahmed AL-OGAILI 1 , Harry E. FUENTES 1, Alfonso J. TAFUR 2, Joseph CAPRINI 3

1 Department of Internal Medicine, John H. Stroger Jr, Hospital of Cook County, Chicago, IL, USA; 2 Department of Medicine, Cardiology-Vascular Medicine, Northshore University HealthSystem, Evanston, IL, USA; 3 Pritzker School of Medicine, NorthShore University HealthSystem, Evanston, IL, USA


PDF


Venous thromboembolism (VTE) is a major source of morbidity and mortality among patients diagnosed with cancer. In addition to an increased risk of VTE, patients with cancer are at higher risk of bleeding while receiving therapeutic anticoagulation. Aggressive and targeted thromboprophylaxis is a crucial practice to avoid the dreaded complications of VTE. Risk assessment models (RAM) are tools developed to identify high-risk patients in whom thromboprophylaxis is beneficial. This review describes the most validated VTE RAMs in patients with cancer.


KEY WORDS: Thrombosis - Venous thromboembolism - Neoplasms - Primary prevention

inizio pagina